Home
Ottar Nygård's picture

Ottar Nygård

Professor
  • E-mailOttar.Nygard@uib.no
  • Phone+47 55 97 30 64
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2017. Ratios of one-carbon metabolites are functional markers of B-vitamin status in a Norwegian coronary angiography screening cohort. Journal of Nutrition. 1167-1173.
  • 2017. Metabolomic evaluation of the consequences of plasma cystathionine elevation in adults with stable angina pectoris. Journal of Nutrition. 1658-1668.
  • 2017. B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials. Journal of Bone and Mineral Research. 1981-1989.
  • 2017. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease. European Journal of Nutrition. 261-272.
  • 2016. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice. Lipids in Health and Disease. 16 pages.
  • 2016. Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. Journal of the American Heart Association. 9 pages.
  • 2016. Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats. Nutrients.
  • 2016. Methylenetetrahydrofolate dehydrogenase 1 polymorphisms modify the associations of plasma glycine and serine with risk of acute myocardial infarction in patients with stable angina pectoris in WENBIT (Western Norway B Vitamin Intervention Trial). Circulation: Cardiovascular Genetics. 541-547.
  • 2016. Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1743-1750.
  • 2016. Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • 2016. Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. European Urology. 941-951.
  • 2016. B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 495-501.
  • 2015. Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients. European Journal of Preventive Cardiology (EJPC). 594-602.
  • 2015. Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 pages.
  • 2015. Trends in 28-day and 1-year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001-2009: A Cardiovascular disease in Norway (CVDNOR) project. Journal of Internal Medicine. 353-361.
  • 2015. Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
  • 2015. Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Osteoporosis International. 1573-1583.
  • 2015. Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. European Journal of Preventive Cardiology (EJPC). 606-614.
  • 2015. Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. European Journal of Preventive Cardiology (EJPC). 872-881.
  • 2015. Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study. International Journal of Cancer. 2932-2939.
  • 2015. Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology. 18-24.
  • 2015. Hypertriglyceridemic-Waist Phenotype is a Useful Global Assessment Tool for Predicting Acute Myocardial Infarction. Journal of Cardiovascular Diseases & Diagnosis. 1-6.
  • 2015. Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study. Atherosclerosis. 115-120.
  • 2015. Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. European Journal of Preventive Cardiology (EJPC). 743-752.
  • 2015. Effect of the Lookback period's length used to identify incident acute myocardial infarction on the observed trends on incidence rates and survival: cardiovascular disease in Norway project. Circulation. Cardiovascular Quality and Outcomes. 376-382.
  • 2015. Dietary intake of saturated fat is not associated with risk of coronary events or mortality in patients with established coronary artery disease. Journal of Nutrition. 299-305.
  • 2015. Clinical significance of late enhancement and regional wall remodeling assessed by 3T magnetic resonance imaging. Clinical Medicine Insights: Cardiology. 17-24.
  • 2015. Circulating B-vitamins and smoking habits are associated with serum polyunsaturated fatty acids in patients with suspected coronary heart disease: A cross-sectional study. PLOS ONE. 14 pages.
  • 2015. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • 2015. A protein extract from chicken reduces plasma homocysteine in rats. Nutrients. 4498-4511.
  • 2015. A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats. Mar. Drugs. Marine Drugs. 5706-5721.
  • 2014. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-gamma-mediated immune activation in the community-based Hordaland health study. British Journal of Nutrition. 1065-1072.
  • 2014. Smoking and body fat mass in relation to bone mineral density and hip fracture: The Hordaland Health Study. PLOS ONE. 9 pages.
  • 2014. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer – a large nested case-control study within the JANUS cohort in Norway. International Journal of Cancer. 197-206.
  • 2014. Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Journal of Bone and Mineral Research. 242-250.
  • 2014. Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. Journal of Nutrition. 784-790.
  • 2014. Interferon-γ-induced inflammatory markers and the risk of cancer: The Hordaland Health Study. Cancer. 3370-3377.
  • 2014. Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study. British Journal of Nutrition. 1085-1095.
  • 2014. Implications of changing definitions of myocardial infarction on number of events and all-cause mortality: the WHO 1979, ESC/ACC 2000, AHA 2003, and Universal 2007 definitions revisited. European Journal of Preventive Cardiology (EJPC). 1349-1357.
  • 2014. Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • 2014. High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue. Journal of Toxicology and Environmental Health, Part A. 1229-1250.
  • 2014. Favorable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1358-1364.
  • 2014. Evidence for increased catabolism of vitamin B-6 during systemic inflammation. American Journal of Clinical Nutrition. 250-255.
  • 2014. Educational inequalities in acute myocardial infarction incidence in Norway: A nationwide cohort study. PLOS ONE. 8 pages.
  • 2014. Educational inequalities in 28 day and 1-year mortality after hospitalisation for incident acute myocardial infarction - A nationwide cohort study. International Journal of Cardiology. 874-880.
  • 2014. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: A prospective cohort study. BMC Cardiovascular Disorders.
  • 2013. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. European Heart Journal. 2689-2696.
  • 2013. Type 2 diabetes genes : present status and data from Norwegian studies. Norsk Epidemiologi. 9-22.
  • 2013. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PLOS ONE. 9 pages.
  • 2013. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. American Journal of Clinical Nutrition. 934-940.
  • 2013. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. International Journal of Epidemiology. 201-210.
  • 2013. Preeclampsia in healthy women and endothelial dysfunction 10 years later. American Journal of Obstetrics and Gynecology. 569.e1-569.e10.
  • 2013. Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 297-303.
  • 2013. Plasma stearoyl-CoA desaturase indices: Association with lifestyle, diet and body composition. Obesity. E294-E302.
  • 2013. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 2041-2048.
  • 2013. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. International Journal of Cardiology. 1435-1440.
  • 2013. Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats. PLOS ONE. 9 pages.
  • 2013. Evaluation of the body adiposity index in a caucasian population: the Hordaland Health Study. American Journal of Epidemiology. 586-592.
  • 2013. Effect of folic acid supplementation on levels of circulating monocyte chemoattractant protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris. PLOS ONE. 11 pages.
  • 2013. Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC Medicine.
  • 2013. Cardiovascular disease and diabetes mellitus in Norway during 1994 -2009: CVDNOR - nationwide research project. Norsk Epidemiologi. 101-107.
  • 2013. Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity. E512-E519.
  • 2013. Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients. PLOS ONE.
  • 2013. An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoE(-/-) mice. PLOS ONE. 14 pages.
  • 2013. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. British Journal of Nutrition. 648-657.
  • 2013. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clinical and Experimental Immunology. 121-130.
  • 2012. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. Journal of Internal Medicine. 583-591.
  • 2012. Relative importance of risk factors for coronary heart disease - The Hordaland Homocysteine Study. Scandinavian Cardiovascular Journal. 316-323.
  • 2012. Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 pages.
  • 2012. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstetrics and Gynecology. 1243-1250.
  • 2012. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids in Health and Disease. 11 pages.
  • 2012. Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. Metabolism: Clinical and Experimental. 1461-1472.
  • 2012. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertility and Sterility. 1620-1626,e1.
  • 2012. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. American Journal of Clinical Nutrition. 1072-1078.
  • 2011. Systemic Markers of Interferon-gamma-Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 698-704.
  • 2011. Poor folate status predicts persistent diarrhea in 6- to 30-month-old north Indian children. Journal of Nutrition. 2226-2232.
  • 2011. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. Journal of Nutrition. 611-617.
  • 2011. Genetic polymorphisms in 15q25 and 19q13 Loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiology, Biomarkers and Prevention. 2250-2261.
  • 2011. Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. Coronary Artery Disease. 270-278.
  • 2011. Cobalamin Status Modifies the Effect of Zinc Supplementation on the Incidence of Prolonged Diarrhea in 6-to 30-Month-Old North Indian Children. Journal of Nutrition. 1108-1113.
  • 2011. A proposed method to investigate reliability throughout a questionnaire. BMC Medical Research Methodology. 7 pages.
  • 2010. Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies. BJOG: An International Journal of Obstetrics and Gynaecology. 667-675.
  • 2010. Systemic Markers of Interferon-–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology.
  • 2010. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. Atherosclerosis. 644-649.
  • 2010. Serum B vitamin levels and risk of lung cancer. Journal of the American Medical Association (JAMA). 2377-2385.
  • 2010. Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • 2010. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a western Norway B vitamin intervention trial (WENBIT) substudy. American Journal of Cardiology. 1577-1584.
  • 2010. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • 2010. Competing risk analysis of events 10 years after revascularization. Scandinavian Cardiovascular Journal. 279-288.
  • 2010. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • 2009. Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infarction, 1979-2001: the Western Norway cardiovascular registry. European Journal of Cardiovascular Prevention & Rehabilitation. 621-627.
  • 2009. Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. European Heart Journal-Cardiovascular Imaging. 858-864.
  • 2009. Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 52-60.
  • 2009. Cysteine, homocysteine and bone mineral density: A role for body composition? Bone. 954-958.
  • 2009. Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • 2008. Sykehusinnleggelser for hjerte- og karsykdom i Helse Vest i perioden 1992-2001. Tidsskrift for Den norske legeforening. 17-23.
  • 2008. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • 2008. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • 2008. Factor structure of the revised Jalowiec Coping Scale in patients admitted for elective coronary angiography*. Scandinavian Journal of Caring Sciences. 596-607.
  • 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • 2008. Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12 pages.
  • 2008. Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12.
  • 2007. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • 2007. Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry. 1209-1218.
  • 2007. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • 2007. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. American Journal of Clinical Nutrition. 1470-1478.
  • 2007. Changes in Atherosclerotic Plaque Volume Measured with Intracoronary Ultrasound during B-vitamin Intervention (a WENBIT substudy). Clinical Chemistry and Laboratory Medicine. A50-P44.
  • 2006. The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • 2006. Relationship between provider-based measures of physical function and self-reported health-related quality of life in patients admitted for elective coronary angiography. Heart & Lung. 11 pages.
  • 2006. Relationship between probider-based measures of physical function and self-reported health-realted quality of life in pasients admitted for elective coronary angiafraphy. Heart & Lung. 90-100.
  • 2006. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • 2006. Effect of vitamin B-12 treatment on haptocorrin. Clinical Chemistry. 1104-1111.
  • 2005. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. European Journal of Clinical Nutrition. 480-488.
  • 2005. Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 277-282.
  • 2004. Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • 2004. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention. American Journal of Clinical Nutrition. 641-648.
  • 2004. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring. 167-172.
  • 2004. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arteriosclerosis, Thrombosis and Vascular Biology. 301-307.
  • 2003. Plasma Vitamin B6 Vitamers before and after Oral Vitamin B6 Treatment: A Randomized Placebo-controlled Study. Clinical Chemistry. 155-161.
  • 2003. Homocysteinstudien i Hordaland. Norsk Epidemiologi. 103-106.
  • 2002. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Archives of Internal Medicine. 1374-1381.
  • 2002. Holo-Transcobalamin Is an Early Marker of Changes in Cobalamin Homeostasis. A Randomized Placebo-controlled Study. Clinical Chemistry. 1768-1771.
  • 2001. Plasma total homocysteine is influenced by prandial status in humans: The Hordaland Homocysteine Study. Journal of Nutrition. 1214-1216.
  • 2001. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clinical Chemistry. 1738-1741.
  • 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 130-136.
  • 1999. Apolipoprotein A1 and risk for coronary artery disease. Scandinavian Cardiovascular Journal. 19.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • 1998. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • 1998. Homocystein og koronarsykdom. Lipid-forum. 17-22.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1997. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • 1996. The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1996. Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1996. Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. Journal of the American Medical Association (JAMA). 1526-1533.
  • 1995. Kolesterolbestemmelse ved sesjon. En måte å identifisere personer med høy risiko for å utvikle hjerte- og karsykdom. Tidsskrift for Den norske legeforening. 3249-3253.
Academic lecture
  • 2020. Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.
  • 2018. Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • 2017. Association between dietary fat intake and coronary heart disease in middle-age adults. The Hordaland Health Study (HUSK) .
  • 2015. Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • 2014. VITAMIN D STATUS AND MORTALITY IN PATIENTS WITH STABLE ANGINA.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • 2010. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • 2007. WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • 2007. WENBIT - Western Norway B-vitamin intervention trial.
  • 2007. Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • 2007. Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • 2007. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • 2002. Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • 2001. Total homocysteine predicts mortality and major coronary events also in simvastatin treated patients of 4S.
  • 2001. Total homocysteine predicts major coronary events and mortality in simvastatin treated patients of 4S.
  • 2001. Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • 2001. Homocysteine predicts mortality and coronary events in 4S patients.
  • 1999. Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • 1999. Apolipoprotein A1 and risk for coronary artery disease.
  • 1998. Plasma total homocysteine: a risk factor for mortality in aortic stenosis patients.
  • 1997. Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • 1997. Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • 1997. Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • 1995. Plasma homocysteine and relation to coffee and tea comsimption.
  • 1995. Plasma homocystein og forbruk av kaffe og te.
Abstract
  • 2015. A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • 2013. DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • 2013. Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • 2012. Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • 2012. INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • 2009. Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • 2009. Detection of non-viable myocardium by 3T MRI in patients without obstructive coronary artery disease. Cardiology. 88-89.
  • 2009. Delayed contrast-enhancement and left ventricular remodelling demonstrated at high-field 3T MRI of patients with suspected coronary artery disease. Cardiology. 82-83.
  • 2008. The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • 2008. The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • 2008. Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • 2008. Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • 2008. Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • 2008. B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • 2008. Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • 2007. Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • 2005. The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • 2005. Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • 2005. Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Academic literature review
  • 2015. The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). 9 pages.
  • 2012. The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. 15 pages.
  • 2010. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals. 1622-1631.
  • 2010. Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. 1632-1642.

More information in national current research information system (CRIStin)

Research groups